Metraipolis › archive › dc_c701dcf663ab
Prevalence of Histological Transformation in First-Line Osimertinib Non-Small Cell Lung Cancers: Case Series and Literature Review — Europe PMC PMID:41226501
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41226501
- DOI
- 10.3390/ijms262110462
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-09T00:17:55.470Z
- SHA-256 of the archived text
2628fc4edb9c49e599f54025e9501294af1b220757ccddaae1c23feec0bda98c- Stable URL of this page
https://metraipolis.com/documento/dc_c701dcf663ab
How to cite
Prevalence of Histological Transformation in First-Line Osimertinib Non-Small Cell Lung Cancers: Case Series and Literature Review — Europe PMC PMID:41226501 — Europe PMC (en), https://europepmc.org/article/MED/41226501 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_c701dcf663ab (Metraipolis archive dc_c701dcf663ab, sha256 2628fc4edb9c49e599f54025e9501294af1b220757ccddaae1c23feec0bda98c)
BibTeX
@misc{dcc701dcf663ab,
title = {Prevalence of Histological Transformation in First-Line Osimertinib Non-Small Cell Lung Cancers: Case Series and Literature Review — Europe PMC PMID:41226501},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41226501},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_c701dcf663ab; sha256 2628fc4edb9c49e599f54025e9501294af1b220757ccddaae1c23feec0bda98c},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41226501. Agents can read the archived copy with the MCP tool read_document.